In esophageal adenocarcinomas, PD-L2 expression is associated with smaller tumor size, early stages, and well-differentiated grade; however, PD-L2 is not associated with lymph node infiltration or metastasis patient survival [44]. The gene discussed is PDCD1LG2; the disease is esophageal adenocarcinoma.